SEC Form 4 · accession 0001246360-15-001409
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 7:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 3, 2015 | A | 7,530 | $16.66 | A | 119,105 | D | |
| Common Stock | Mar 3, 2015 | M | 132 | $4.54 | A | 119,237 | D | |
| Common Stock | Mar 3, 2015 | M | 9,746 | $0.00 | A | 128,983 | D | |
| Common Stock | Mar 3, 2015 | M | 3,675 | $0.00 | A | 132,658 | D | |
| Common Stock | Mar 3, 2015 | F | 3,168 | $16.66 | D | 129,490 | D | |
| Common Stock | Mar 3, 2015 | S | 132 | $17.05 | D | 129,358 | D | |
| Common Stock | Mar 4, 2015 | F | 1,195 | $16.95 | D | 128,163 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.66 | Mar 3, 2015 | A | 102,529 | A | Apr 3, 2015 | Mar 2, 2025 | Common Stock | 102,529 | 102,529 | D |
| Restricted Stock UnitF3 | $0.00 | Mar 3, 2015 | A | 29,239 | A | Mar 3, 2015 | Mar 3, 2017 | Common Stock | 29,239 | 29,239 | D |
| Stock Option (Right to Buy) | $4.54 | Mar 3, 2015 | M | 132 | D | Apr 27, 2008 | Mar 26, 2015 | Common Stock | 132 | 136 | D |
| Restricted Stock UnitF4 | $0.00 | Mar 3, 2015 | M | 9,746 | D | Mar 3, 2015 | Mar 3, 2017 | Common Stock | 9,746 | 19,493 | D |
| Restricted Stock UnitF6 | $0.00 | Mar 4, 2015 | M | 3,675 | D | Mar 4, 2013 | Mar 4, 2015 | Common Stock | 3,675 | 0 | D |
Explanation of responses
- F1The stock option becomes exercisable in 48 equal monthly installments beginning April 3, 2015.
- F2Payment in stock of short-term incentive award pursuant to the 2014 Corporate Bonus Plan.
- F3Award granted pursuant to the 2014 Performance Share Plan, vesting in 3 equal annual installments beginning March 3, 2015.
- F4Vesting of award granted pursuant to the 2014 Performance Share Plan.
- F5This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2014.
- F6Vesting of award granted pursuant to the 2012 Performance Share Plan.